Valeant Stock Tumbles on $750 Million Debt Offering Announcement
In late October, the company announced it was on pace to exceed an earlier goal of paying down $5 billion in debt by February 2018.

Valeant Pharmaceuticals Int'l Inc. (VRX) shares dipped 1.63% to $15.13 in mid-morning trading Monday, Nov. 13, after the drug maker launched a $750 million debt offering.

Valeant announced the private offering with notes due in 2025 in a statement Monday. The proceeds from the offering of the existing 5.5% senior secured notes will be used to repay a portion of term loan facilities due in 2022, Valeant said.

In late October, the company announced it was on pace to exceed an earlier goal of paying down $5 billion in debt by February 2018. Valeant still has more than $26 billion in debt, but no obligations until 2020.

Valeant stock has gained 4.27% since the start of the year, compared to the broader S&P 500 Index's 15.3% gain in the same period.

More of What's Trending on TheStreet:

More from Stocks

Wait, Google Was Almost Called What?

Wait, Google Was Almost Called What?

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Apple Suppliers Slide After European, Asian Chipmakers Echo Smartphone Concerns

Alphabet, Caterpillar, Coca-Cola and Amazon - 5 Things You Must Know

Alphabet, Caterpillar, Coca-Cola and Amazon - 5 Things You Must Know

Tech Stocks Have You Baffled? Educate Yourself in Some Portfolio Diversification

Tech Stocks Have You Baffled? Educate Yourself in Some Portfolio Diversification

Alphabet Shares Rise on Earnings, Revenue Beat But Some Concerns Remain

Alphabet Shares Rise on Earnings, Revenue Beat But Some Concerns Remain